What is it about?

This publication highlights a common entry route used by several viruses to infect human hosts. Their entry pattern subdues related genetic pathways leading to inhibition of Major Histocompatibility Class I genes.

Featured Image

Why is it important?

This work brings to light the role of LCK a key gene whose role is critical to viral inhibition but viral pathogens turn to control its splicing machinery rendering it non functional. This will guide new therapeutic decisions addressed by our group

Perspectives

This work is critical and comes at a time when a lot of viral infections and related epidemics like Ebola in West Africa and Rift Valley fever in Kenya and East Africa, are still poorly addressed because of lack of understanding of viral parthenogenesis. This study brings to light a common pathway differentially exploited by viruses for their pathogenic gains. Therefore, identification of pathogenic driver genes and development of cut-across therapy is our focus

Dr Daniel A Achinko
National Institutes of Health

Read the Original

This page is a summary of: Identification of genetic pathways driving Ebola virus disease in humans and targets for therapeutic intervention, F1000Research, December 2016, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.9778.1.
You can read the full text:

Read
Open access logo

Resources

Contributors

The following have contributed to this page